IPQ Inside the global regulatory dialogue

California’s Findings of Gaps in Heparin Recalls Highlighted at FDA Track and Trace Workshop

Feb 17th, 2011

Please Log in to print the full article

Evidence of the gaps in the 2008 heparin recall process uncovered by the State of California underscores the need for a track and trace system for prescription drug products, CA State Board of Pharmacy Executive...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications